- Advertisement -
- Advertisement -

Related

Looking for Michelin star quality Market Neutral strategies

Report: Alternative Fixed Income

- Advertisement -

Stockholm (HedgeNordic) – Ludwig Holmgren, Head of Capital Introduction at SEB in Stockholm, discusses what makes Market Neutral strategies attractive for institutional investors.

In theory, Market Neutral is a great idea for any portfolio; a costeffective uncorrelated asset. As fixed-income is not a lucrative option nowadays, Market Neutral should constitute an attractive alternative for any investor. However, for some, this style still doesn’t currently have the status it deserves. Ludwig explains: “For any product you add to your portfolio as an institutional investor, you will ask yourself: what do I add for my clients? Does this product provide the right level of expertise? And then you will care about how you will explain that to the board.”

In medium and smaller organisations, this means staying away from complex products. In larger institutions, investment parameters are well defined in terms of risk, return target, liquidity and costs, which could de facto exclude some Market Neutral strategies. First, let us define what Market Neutral strategies are and how we can categorise them. In terms of assets, potentially any asset that has an exposure to the market can be hedged out and thereby “neutralized”. Clearly the most common Market Neutral asset class is equity, but we find some fixed income and convertibles as well as a mix of assets in various arbitrage and systematic strategies. “Convertible arbitrage in particular presents interesting opportunities nowadays, says Ludwig, as most of the large prop desks that held huge trades left the market after the Volcker rules were implemented.

” Typically, any of these Market Neutral types falls into two categories: the fundamental and the quantitative strategies. This was easy. Now, one who speaks about Market Neutral automatically implies alpha generation and that’s where we need to call in the experts. The proper evaluation of risk and risk premia is key to isolating alpha. On average, quantitative managers are more successful in identifying, and perhaps more importantly explaining, risk than fundamental managers are.

To read the whole interview in the HedgeNordic Special Report on market neutral strategies, please click here: Market Neutral Strategies 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.

Latest Articles

Asilo Argo Shifts Portfolio Focus Toward AI

Stockholm (HedgeNordic) – At Asilo Argo, portfolio managers Ernst Grönblom and Henri Blomster employ a high-conviction strategy aimed at identifying “future superstar” stocks. With...

Tessin Doubles Stake in Alfakraft Fonder

Stockholm (HedgeNordic) – Tessin, a Swedish digital investment platform for real estate financing, has agreed to double its stake in alternative asset manager Alfakraft...

Tech Power-Up for Tidan with CTO Appointment

Stockholm (HedgeNordic) – Tidan Capital has transformed from a single-strategy fund into a multi-fund boutique, a shift that demands robust technology infrastructure. To support...

Five Years In: From Quiet Start to Strong Finish

Stockholm (HedgeNordic) – Nordea Asset Management’s Copenhagen-based office is home to a team of portfolio managers and analysts dedicated to capturing relative-value opportunities in...

Month in Review – November 2024

Stockholm (HedgeNordic) – As the year approaches its end, the Nordic hedge fund industry is on track for its third-best performance on record and...

Origo Fonder Shifts Gears with Per Johansson as Co-CIO

The summer of 2024 brought an injection of momentum for fund boutique Origo Fonder, as Bodenholm founder Per Johansson joined as Co-Chief Investment Officer...

Allocator Interviews

In-Depth: Megatrends

Voices

Request for Proposal

- Advertisement -